Neuraptive Therapeutics, Inc. Announces Positive 24-Week Dat

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in the Phase 2 NEUROFUSE Study, Reinforcing Previously Announced Proof of Concept 12-Week Data

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in the Phase 2 NEUROFUSE Study, Reinforcing Previously Announced Proof of Concept 12-Week Data

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Michigan , United States , Evanl Tzanis , Evan Tzanis , Davidm Brogan , Neuraptive Therapeutics Inc , Washington University In St , Neuraptive Therapeutics , Business Wire , Michigan Hand Questionnaire , Numerical Pain Rating Scale , Associate Professor , Orthopedic Surgery , Washington University , Lead Author , Chief Operating Officer ,